Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, Theil A, Eugster A, Puff R, Peplow C, Buettner F, Lange K, Hasford J, Achenbach P; Pre-POINT Study Group.
Bonifacio E, et al. Among authors: achenbach p.
JAMA. 2015 Apr 21;313(15):1541-9. doi: 10.1001/jama.2015.2928.
JAMA. 2015.
PMID: 25898052
Clinical Trial.